| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0021 | 1 |